BR112022020899A2 - Método para tratamento de um meio de cultura celular, meio de cultura celular, uso do meio e método para produzir uma proteína recombinante - Google Patents

Método para tratamento de um meio de cultura celular, meio de cultura celular, uso do meio e método para produzir uma proteína recombinante

Info

Publication number
BR112022020899A2
BR112022020899A2 BR112022020899A BR112022020899A BR112022020899A2 BR 112022020899 A2 BR112022020899 A2 BR 112022020899A2 BR 112022020899 A BR112022020899 A BR 112022020899A BR 112022020899 A BR112022020899 A BR 112022020899A BR 112022020899 A2 BR112022020899 A2 BR 112022020899A2
Authority
BR
Brazil
Prior art keywords
cell culture
culture media
medium
producing
treatment
Prior art date
Application number
BR112022020899A
Other languages
English (en)
Inventor
Popp Oliver
Ken Shiratori Masaru
Original Assignee
Genentech Inc
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc, Hoffmann La Roche filed Critical Genentech Inc
Publication of BR112022020899A2 publication Critical patent/BR112022020899A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0681Cells of the genital tract; Non-germinal cells from gonads
    • C12N5/0682Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/05Inorganic components
    • C12N2500/10Metals; Metal chelators
    • C12N2500/20Transition metals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/32Amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2523/00Culture process characterised by temperature

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

MÉTODO PARA TRATAMENTO DE UM MEIO DE CULTURA CELULAR, MEIO DE CULTURA CELULAR, USO DO MEIO E MÉTODO PARA PRODUZIR UMA PROTEÍNA RECOMBINANTE. A divulgação refere-se a métodos para manipulação e suplementação de meio de cultura celular para melhorar o desempenho do processo em sistemas de expressão recombinante eucarióticos.
BR112022020899A 2020-04-15 2021-04-14 Método para tratamento de um meio de cultura celular, meio de cultura celular, uso do meio e método para produzir uma proteína recombinante BR112022020899A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063010536P 2020-04-15 2020-04-15
PCT/EP2021/059690 WO2021209512A1 (en) 2020-04-15 2021-04-14 Method for medium treatment before inoculation

Publications (1)

Publication Number Publication Date
BR112022020899A2 true BR112022020899A2 (pt) 2022-12-27

Family

ID=75674775

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022020899A BR112022020899A2 (pt) 2020-04-15 2021-04-14 Método para tratamento de um meio de cultura celular, meio de cultura celular, uso do meio e método para produzir uma proteína recombinante

Country Status (12)

Country Link
US (1) US20230279342A1 (pt)
EP (1) EP4136212A1 (pt)
JP (1) JP2023521236A (pt)
KR (1) KR20230002642A (pt)
CN (1) CN115397971A (pt)
AU (1) AU2021257609A1 (pt)
BR (1) BR112022020899A2 (pt)
CA (1) CA3175256A1 (pt)
IL (1) IL297191A (pt)
MX (1) MX2022012829A (pt)
TW (1) TW202204602A (pt)
WO (1) WO2021209512A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023157970A1 (ja) * 2022-02-21 2023-08-24 中外製薬株式会社 灌流培養方法
CN115747138B (zh) * 2022-12-01 2024-03-08 苏州依科赛生物科技股份有限公司 一种hek 293细胞培养基及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL87737A (en) 1987-09-11 1993-08-18 Genentech Inc Method for culturing polypeptide factor dependent vertebrate recombinant cells
US6030945A (en) 1996-01-09 2000-02-29 Genentech, Inc. Apo-2 ligand

Also Published As

Publication number Publication date
AU2021257609A1 (en) 2022-11-10
JP2023521236A (ja) 2023-05-23
TW202204602A (zh) 2022-02-01
CN115397971A (zh) 2022-11-25
CA3175256A1 (en) 2021-10-21
WO2021209512A1 (en) 2021-10-21
EP4136212A1 (en) 2023-02-22
IL297191A (en) 2022-12-01
US20230279342A1 (en) 2023-09-07
KR20230002642A (ko) 2023-01-05
MX2022012829A (es) 2022-11-07

Similar Documents

Publication Publication Date Title
BR112022020899A2 (pt) Método para tratamento de um meio de cultura celular, meio de cultura celular, uso do meio e método para produzir uma proteína recombinante
AR124871A2 (es) Métodos de fabricación para el control del contenido de lisina c-terminal, galactosa y ácido siálico en proteínas recombinantes
WO2019126634A3 (en) Targeted integration of nucleic acids
ES2572214T3 (es) Métodos para expansión celular y usos de células y medios acondicionados producidos de este modo para terapia
BR112018011902A2 (pt) método de fermentação, levedura geneticamente modificada, construto de ácido nucleico, vetor, célula hospedeira, meio de fermentação e utilização da levedura geneticamente modificada
BRPI0919804A8 (pt) Métodos e composição para o tratamento de problemas dermatológicos e/ou condições de cabelo
BR112012014454A2 (pt) uso de promotores indutíveis na produção de metionina
EA202091349A1 (ru) Способы культивирования клеток
EA201492185A1 (ru) Способ получения рекомбинантной идуронат-2-сульфатазы
BR112016028512A8 (pt) método de cultivo de uma célula de mamífero e método de produção de uma proteína recombinante
BR112018014520A2 (pt) carbonato de cálcio amorfo estabilizado para tratamento de doenças e afecções neurológicas, musculares e de infertilidade
BR112018015626A2 (pt) sistema fúngico de produção de alto nível de proteínas
BR112018017340A2 (pt) método para produzir um aminoácido básico ou um produto de fermentação contendo o aminoácido básico
DE602004025011D1 (de) Verfahren zur herstellung rekombinanter proteine
EA201000945A1 (ru) Конструирование системы секреции на основе sm-белков
BRPI0914805B8 (pt) método para replicar vírus em uma cultura de células scldk, processo para adaptar células cldk dependentes do substrato para desenvolvimento em suspensão, método para propagar continuamente células scldk em suspensão, e, composição
BR112022015325A2 (pt) Sistemas e métodos para alta produção de microganismos recombinantes e uso dos mesmos
AU2018276376A1 (en) Cell culture methods
EP4235175A3 (en) Methods for culturing human keratinocytes
BR112021014805A2 (pt) Métodos de produção para uma proteína recombinante e para aumentar o volume de produção
BR112017017303B8 (pt) Método para obtenção de clones de células de alta produtividade
CL2023000576A1 (es) Estrategias de suministro con asparagina para mejorar el rendimiento del cultivo celular y mitigar las variantes de secuencia de asparagina.
BR112018007314A2 (pt) método para melhorar o crescimento da levedura para produção de bio-produtos, método para produção de bio-produtos fermentativos, composição nutriente de fermentação e mistura líquida
MX2020013633A (es) Metodos para producir proteinas recombinantes.
WO2019238143A3 (zh) 结直肠癌实体瘤原代细胞和结直肠癌腹水原代肿瘤细胞培养方法及配套试剂